Effect of Different Manipulations on Serum Prostate-Specific Antigen (PSA) Level in Patients with Symptomatic Benign Prostatic Hyperplasia and Suspicion of Carcinoma Prostate

被引:0
|
作者
Ahmad, Ashfaq [1 ]
Iqbal, Muhammad [1 ]
Hassan, Sohail [2 ]
Jehan-Ur-Rehman, Shah [3 ]
Bashir, Ammar [4 ]
机构
[1] Social Secur Teaching Hosp Lahore, Urol, Lahore, Pakistan
[2] Social Secur Teaching Hosp Lahore, Lahore, Pakistan
[3] Lahore Gen Hosp, Urol, Lahore, Pakistan
[4] AFIU Rawalpindi, Urol, Rawalpindi, Pakistan
来源
关键词
Prostatic specific antigen; benign prostatic hyperplasia; Carcinoma prostate; DIGITAL RECTAL EXAMINATION; PROTEASE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Prostate specific antigen is an organ specific marker. A temporary rise in prostate specific antigen serum level has been reported in various situations like, digital rectal examination, urethral catheterization, transurethral resection of prostate and transrectal ultrasound guided prostatic needle biopsy. Methodology: This comparative study is conducted at Department of Urology and Renal Transplantation Div, HQ. Teaching Hospital Mirpur Azad Kashmir from 1st June 2017 to 31st May 2018. Patients with symptomatic benign prostate hyperplasia and suspicion of carcinoma prostate on digital rectal examination with age above 50 years were included. All patients were divided into four groups. Group A comprised, patients who underwent digital rectal examination. Group B comprised, patients who underwent transurethral resection of prostate. Group C comprised, patients who underwent transurethral Foley catheterization due to retention of urine. Group D comprised, patients who underwent transrectal ultrasound guided prostatic needle biopsy for suspicion of ca prostate on digital rectal examination. Serum PSA was detected by enzyme linked immunosorbent serum assay (ELISA) method. Results: In group A pre manipulation mean serum PSA level was 1.22ng/ml, after 30 minutes it was 2.52ng/ml, where as after 72 hrs mean serum PSA level was 1.56ng/ml and after one week it dropped to 1.1ng/ml. In group B pre manipulation mean serum PSA level was 3.41ng/ml, after 30 minutes of manipulation it was 29.89ng/ml, after 72 hours and one week of manipulation it was 8.22ng/ml and 4.25ng/ml respectively and after 2 weeks it dropped to 3.78ng/ml. In group C pre manipulation mean serum PSA level was 2.81ng/ml, after 30 minutes it was 4.54ng/ml, where as after 72 hrs and 1 week of manipulation it was 3.76ng/ml and 2.40ng/ml respectively. In group D pre manipulation mean serum PSA level was 2.61ng/ml, after 30 minutes it was 4.53ng/ml, where as after 72 hrs and 1 week of manipulation it was 3.42ng/ml and 2.56ng/ml respectively. Conclusion: There is significant rise in serum prostate specific antigen after different manipulations except DRE.
引用
收藏
页码:840 / 843
页数:4
相关论文
共 50 条
  • [1] Role of Prostate-Specific Antigen (PSA) in Patients with Benign Prostate Hyperplasia
    Duvedi, Priya
    Singh, Harjinder
    Bedi, Gurdeep Kaur
    Kaur, Maninder
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2019, 13 (05) : BC01 - BC03
  • [2] Prostate-specific antigen as an estimator of prostate volume in the management of patients with symptomatic benign prostatic hyperplasia
    Mochtar, CA
    Kiemeney, LALM
    van Riemsdijk, MM
    Barnett, GS
    Laguna, MP
    Debruyne, FMJ
    de la Rosette, JJMCH
    EUROPEAN UROLOGY, 2003, 44 (06) : 695 - 700
  • [3] Effect of transurethral indwelling catheter on serum prostate-specific antigen level in benign prostatic hyperplasia
    Batislam, E
    Arik, AI
    Karakoc, A
    Uygur, MC
    Germiyanoglu, RC
    Erol, D
    UROLOGY, 1997, 49 (01) : 50 - 54
  • [4] Benign prostatic hyperplasia and prostate-specific antigen
    Pejcic, Tomislav
    Acimovic, Miodrag
    Dzamic, Zoran
    Radovanovic, Milan
    Hadzi-Djokic, Jovan
    VOJNOSANITETSKI PREGLED, 2015, 72 (05) : 447 - 453
  • [5] AUTOANTIBODIES TO PROSTATE-SPECIFIC ANTIGEN IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
    ZISMAN, A
    ZISMAN, E
    LINDNER, A
    VELIKANOV, S
    SIEGEL, YI
    MOZES, E
    JOURNAL OF UROLOGY, 1995, 154 (03): : 1052 - 1055
  • [6] PROSTATE-SPECIFIC ANTIGEN IN THE EXPRESSED PROSTATIC FLUID OF MEN WITH BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CARCINOMA
    KIM, ED
    SMITH, ND
    GRAYHACK, JT
    JOURNAL OF UROLOGY, 1995, 154 (05): : 1802 - 1805
  • [7] Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia
    Roehrborn, CG
    Boyle, P
    Gould, AL
    Waldstreicher, J
    UROLOGY, 1999, 53 (03) : 581 - 589
  • [8] Seminal plasma prostate-specific antigen level in benign prostatic hyperplasia
    Senkul, T
    Narin, Y
    Iseri, C
    Sen, B
    Karademir, K
    Erden, D
    UROLOGIA INTERNATIONALIS, 2004, 72 (04) : 332 - 334
  • [9] Prostate specific antigen (PSA) levels in health, prostatic carcinoma and benign prostatic hyperplasia
    Dosoo, D. K.
    Botchway, F. A.
    Adu-Gyamfi, C.
    Amanquah, S. D.
    CLINICAL CHEMISTRY, 2006, 52 (06) : A166 - A166
  • [10] Serum-to-urinary prostate-specific antigen ratio in patients with benign prostatic hyperplasia and prostate cancer
    Hillenbrand, M
    Bastian, M
    Steiner, M
    Zingler, C
    Müller, M
    Wolff, JM
    Seiter, H
    Schuff-Werner, P
    ANTICANCER RESEARCH, 2000, 20 (6D) : 4995 - 4996